Venous Thromboembolism » Antiphospholipid Syndrome

Abstract Number: PB1057

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

C. Farkh¹, S. Ellouze¹, L. Gounelle¹, M. Sad-Houari¹, J. Duchemin¹, V. Proulle¹, M. Fontenay^1,2, X. Delavenne^3,4, G. Jourdi^1,5,6,7

Abstract Number: PB1055

A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis

N. Pozzi¹, V. Pengo²

Abstract Number: PB1068

A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus

I. Krichen¹, S. Samet¹, F. Megdich¹, M. Hsairi², L. Gargouri², A. Mahfoudh², C. Kallel¹

Abstract Number: PB1054

Artificial Intelligence Classifies APS in Anticoagulated Patients Based on Thrombin Generation

R. de Laat-Kremers¹, D. Wahl², S. Zuily², M. Ninivaggi¹, W. Chayoua¹, V. Regnault², J. Musial³, P. de Groot¹, K. Devreese⁴, B. de Laat¹

Abstract Number: PB1064

Automated Methods for the Enhancement of Lupus Anticoagulant Mixing Study Sensitivities

Z. Cao¹, R. Bottenus¹, C. Kung¹

Abstract Number: OC 44.1

Clinical Characteristics and Prognosis of Antiphospholipid Syndrome Patients Based on Cluster Analysis: A 10-year Cohort Study

W. Qi¹, J. Zhao^1,2, X. Tian^1,2, M. Li^1,2, X. Zeng^1,2

Abstract Number: PB1051

Clinical Course of Thrombotic Antiphospholipid Syndrome with Positive IgA Anticardiolipin or IgA β2-glycoprotein I

L. Figueiredo¹, B. Mazetto², A.P. dos Santos², B. Jacintho², C. Vaz², J.D. Oliveira³, G. Mesquita², J. Annichino-Bizzachi², F. Orsi²

Abstract Number: PB1063

Clinico-pathologic Characterization of Patients Tested for Antiphospholipid Syndrome at a Tertiary Care Hospital

K. Sajeeve¹, D. K.V¹, V. V¹, A. Catherine Jacob¹, D. Sidharth¹, D. Vidyadharan¹

Abstract Number: PB1050

Could the Adjusted Version of the Global Antiphospholipid Syndrome Score (aGAPSS) Be a Useful Tool to Select Patients with Primary Obstetric Antiphospholipid Syndrome (POAPS) for Primary Thromboprophylaxis with Aspirin?

S. Udry¹, F. Aranda¹, S. Perés Wingeyer¹, S. Stephanie Morales Perez², C. Belizna³, J. Alijotas-Reig⁴, E. Esteve-Valverde², D.S. Fernández Romero⁵, J.O. Latino⁵, G. de Larrañaga¹

Abstract Number: PB1053

Effect of Hydroxychloroquine on the Levels of Inflammatory Cytokines and Tissue Factor in Patients with Primary Antiphospholipid Syndrome

B. Mazetto¹, S. Saraiva², B. Jacintho², G. Vieira-Damiani^3,1, C. Vaz², J.D. Oliveira², A.P. dos Santos⁴, G. Mesquita⁴, J. Annichino-Bizzacchi^2,5, F. Orsi^5,6

Abstract Number: PB1059

Evaluation of a Gene Signature Related to Thrombotic Manifestations in Antifospholipid Syndrome

B. Jacintho¹, B. Mazetto², B. Hounkpe³, A.P. Santos⁴, C. Vaz¹, G. Vechiatto⁴, J. Oliveira¹, E. de Paula^5,2, F. Orsi^5,6

Abstract Number: PB1066

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban at Lupus Anticoagulans Positive Patients

L. Slavik¹, J. Jacova², D. Friedecky², J. Ulehlova¹, P. Bradacova¹, A. Skoumalova³, J. Prochazkova¹, A. Hlusi¹, M. Palova¹, A. Kvasnička², E. Ivanovova², B. Pisklakova²

Abstract Number: PB1067

Laboratory Testing Platform Discrepancy between Current Singleplex-assay and New Multiplex-assay for Detecting and Quantifying IgM-anti-Cardiolipin-antibodies and other Anti-Phospholipid (APL)-antibodies: The Potential for Mis-diagnosis of the APL-syndrome

M. Escobar¹, T.E. Howard², N. Montanez¹

Abstract Number: OC 44.4

Origin of Antiphospholipid Antibodies in Autoimmunity and Viral Infection

N. Müller-Calleja¹, A. Hollerbach¹, N. Lemmermann², W. Ruf³, K. Lackner¹

Abstract Number: PB1061

Plasmocytoid Dendritic Cells Activity in Asymptomatic Antiphospholipid Carriers and in Primary and Secondary Antiphospholipid Syndrome with Thrombosis

A.P. Rosa dos Santos¹, B. Cardoso Jacintho², C. de Oliveira Vaz², G. Lisiane Tripiquia Vechiatto Mesquita¹, J.D. Oliveira², J. Annichino-Bizzacchi³, S. Appenzeller⁴, B. Moraes Mazetto⁵, F. A. Orsi⁶

Abstract Number: PB1060

Platelet Activity from Antiphospholipid Syndrome (APS) Patients is Enhanced: Possible Role of the ADP Signaling Pathway

G. Leonardi¹, C.H. Lescano¹, A.P.R. Dos Santos², B.C. Jacinto², B.M. Mazetto², F.A. Orsi^3,4, F.Z. Mónica¹

Abstract Number: OC 44.2

Predictors of Lupus Anticoagulant Test Variability over Time and its Associations with Future Thrombotic Events: Results from the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

M. Colling^1,2, F. Posch^1,3, S. Koder¹, C. Ay¹, I. Pabinger¹, J. Gebhart¹

Abstract Number: OC 44.3

Progression of Ischaemic and Haemorrhagic Brain Lesions on MRI in APS Patients on Antithrombotic Therapy

M. Efthymiou^1,2, P. SvrKova^3,4,2, R. Moll^1,2, S. Nallamilli^1,2, A.R. Alexandre^5,6, D. Isenberg^6,2, D. Werring^3,4,2, R.H Jager^3,4,2, H. Cohen^1,2

Abstract Number: PO164

Real World Experience Use of DOAC in APLS Patients

Y.Y. Yap¹, R.b. Ramli¹, J. Suriar², J. Sathar¹

Abstract Number: PB1052

Risk Factors for Recurrent Thrombosis and Cause of Death in Patients with Antiphospholipid Syndrome; A Swedish Cohort Study

N. Karandyszowska¹, H. Alagündüz¹, J. Oesman¹, M. Magnusson², E. Svenungsson³, A. Antovic³, M. Bruzelius¹